References
Hauser WA, Beghi E. First seizure definitions and world-wide incidence and mortality. Epilepsia. 2008;49(Suppl 1):8–12.
Institute of Medicine. Epilepsy across the spectrum: promoting health and understanding. Washington, DC: The National Academies Press; 2012. p. 292–306.
Commission on Epidemiology and Prognosis, International League Against Epilepsy. Guidelines for epidemiologic studies on epilepsy. Epilepsia. 1993;34:592–6.
Krumholz A, Wiebe S, Gronseth G, et al. Practice parameter: evaluating an apparent unprovoked first seizure in adults (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2007;69:1996–2007.
Krumholz A, Wiebe S, Gronseth G, et al. Evidence-based guideline: management of an unprovoked first seizure in adults. Report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2015;84:1705–13.
Hirtz D, Ashwal S, Berg A, et al. Practice parameter: evaluating a first nonfebrile seizure in children. Report of the Quality Standards Subcommittee of the American Academy of Neurology, the Child Neurology Society, and the American Epilepsy Society. Neurology. 2000;55:616–23.
American College of Emergency Physicians Clinical Policies Subcommittee on Seizures. Clinical policy: critical issues in the evaluation and management of adult patients presenting to the emergency department with seizures. Ann Emerg Med. 2014;63:437–47.
King MA, Newton MR, Jackson GD, et al. Epileptology of first seizure presentation: a clinical, electroencephalographic and magnetic resonance imaging study of 300 consecutive patients. Lancet. 1998;352:1007–11.
Fountain NB, Van Ness PC, Swain-Eng R, et al. Quality improvement in neurology: AAN epilepsy quality measures. Report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology. Neurology. 2011;76:94–9.
Fountain NB, Van Ness PC, Bennett A, et al. Quality improvement in neurology: epilepsy update. Quality measure set. Neurology. 2015;84:1483–7.
Firkin A, Marco DJT, Saya S, et al. Mind the gap: multiple events and lengthy delays before presentation with a “first seizure”. Epilepsia. 2015;56:1534–42.
Hauser WA, Rich SS, Lee JR-J, et al. The risk of recurrent seizures after two unprovoked seizures. New Engl J Med. 1988;338(7):429–34.
Jacoby A, Gamble C, Doughty J, et al. Quality of life outcomes of immediate or delayed treatment of early epilepsy and single seizures. Neurology. 2007;68:1188–96.
Fisher RS, Acevedo C, Arzimanoglou A, et al. A practical clinical definition of epilepsy. Epilepsia. 2014;55(4):475–82.
First Seizure Trial Group. Randomized clinical trial on the efficacy of antiepileptic drugs in reducing the risk of relapse after a first unprovoked tonic-clonic seizure. Neurology. 1993;43:478–83.
Marson A, Jacoby A, Johnson A, et al. Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomized controlled trial. Lancet. 2005;365:2007–13.
Chandra B. First seizure in adults: to treat or not to treat. Clin Neurol Neurosurg. 1992;94(Suppl):S61–3.
Gilad R, Lampl Y, Gabbay U, et al. Early treatment of a single generalized tonic-clonic seizure to prevent recurrence. Arch Neurol. 1996;53:1149–52.
Ruggles KH, Haessly SM, Berg RL. Prospective study of seizures in the elderly in the Marshfield Epidemiologic Study Area (MESA). Epilepsia. 2001;42:1594–9.
French JA, Kanner AM, Bautista J, et al. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy. Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2004;62:1252–60.
Ramsay E, Faught E, Krumholz A, For the CAPSS-272 Study Group, et al. Efficacy, tolerability, and safety of rapid initiation of topiramate versus phenytoin in patients with new-onset epilepsy: a randomized double-blind clinical trial. Epilepsia. 2010;51:1970–77.
Perruca P, Jacoby A, Marson AG, et al. Adverse antiepileptic drug effects in new-onset seizures: a case control study. Neurology. 2011;76:273–9.
Bonnett LJ, Shukralla A, Tudur-Smith C, et al. Seizure recurrence after antiepileptic drug withdrawal and the implications for driving: further results from the MRD Antiepileptic Drug Withdrawal Study and a systematic review. J Neurol Neurosurg Psychiatry. 2011;82(1328–1333):24.
Scottish Intercollegiate Guidelines Network (SIGN). Diagnosis and management of epilepsy in adults. Edinburgh: SIGN; 2015: SIGN publication no. 143. [May 2015]. Available from: http://www.sign.ac.uk. Accessed 11 Feb 2016.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
Dr. Gloss is a paid evidence-based medicine consultant for the American Academy of Neurology, and Level of Evidence Associate Editor for Neurology. Dr. Krumholz serves on the editorial board for Clinical EEG and Neuroscience, and has received royalties from UpToDate.
Conflict of interest
Dr. Gloss was a member of the two American Academy of Guidelines Development Committees on unprovoked first seizures in adults that are discussed in this commentary. Dr. Krumholz was the chair and a member of the two American Academy of Guidelines Development Committees on unprovoked first seizures in adults that are discussed in this commentary.
Rights and permissions
About this article
Cite this article
Gloss, D.S., Krumholz, A. Managing an Unprovoked First Seizure in Adults. CNS Drugs 30, 179–183 (2016). https://doi.org/10.1007/s40263-016-0321-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40263-016-0321-z